BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27495222)

  • 1. Impaired Cardiolipin Biosynthesis Prevents Hepatic Steatosis and Diet-Induced Obesity.
    Cole LK; Mejia EM; Vandel M; Sparagna GC; Claypool SM; Dyck-Chan L; Klein J; Hatch GM
    Diabetes; 2016 Nov; 65(11):3289-3300. PubMed ID: 27495222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy.
    Cole LK; Mejia EM; Sparagna GC; Vandel M; Xiang B; Han X; Dedousis N; Kaufman BA; Dolinsky VW; Hatch GM
    J Mol Cell Cardiol; 2020 Jul; 144():24-34. PubMed ID: 32418915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
    Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of high dietary lipid intake and related metabolic disorders on the abundance and acyl composition of the unique mitochondrial phospholipid, cardiolipin.
    Feillet-Coudray C; Fouret G; Casas F; Coudray C
    J Bioenerg Biomembr; 2014 Oct; 46(5):447-57. PubMed ID: 24951897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DJ-1 Deficiency Protects Hepatic Steatosis by Enhancing Fatty Acid Oxidation in Mice.
    Xu M; Wu H; Li M; Wen Y; Yu C; Xia L; Xia Q; Kong X
    Int J Biol Sci; 2018; 14(13):1892-1900. PubMed ID: 30443192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance.
    Wang X; Xin L; Duan Z; Zuo Z; Wang Y; Ren Y; Zhang W; Sun X; Liu X; Ge L; Yang X; Yao Z; Yang J
    FASEB J; 2019 Mar; 33(3):3731-3745. PubMed ID: 30521378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity.
    Li J; Romestaing C; Han X; Li Y; Hao X; Wu Y; Sun C; Liu X; Jefferson LS; Xiong J; Lanoue KF; Chang Z; Lynch CJ; Wang H; Shi Y
    Cell Metab; 2010 Aug; 12(2):154-65. PubMed ID: 20674860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
    Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tafazzin Deficiency Reduces Basal Insulin Secretion and Mitochondrial Function in Pancreatic Islets From Male Mice.
    Cole LK; Agarwal P; Doucette CA; Fonseca M; Xiang B; Sparagna GC; Seshadri N; Vandel M; Dolinsky VW; Hatch GM
    Endocrinology; 2021 Jul; 162(7):. PubMed ID: 34019639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine diet-induced obesity remodels cardiac and liver mitochondrial phospholipid acyl chains with differential effects on respiratory enzyme activity.
    Sullivan EM; Fix A; Crouch MJ; Sparagna GC; Zeczycki TN; Brown DA; Shaikh SR
    J Nutr Biochem; 2017 Jul; 45():94-103. PubMed ID: 28437736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
    Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
    Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator-Activated Receptor α.
    Chen X; Zhang F; Gong Q; Cui A; Zhuo S; Hu Z; Han Y; Gao J; Sun Y; Liu Z; Yang Z; Le Y; Gao X; Dong LQ; Gao X; Li Y
    Diabetes; 2016 Jul; 65(7):1904-15. PubMed ID: 27207533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet.
    Camer D; Yu Y; Szabo A; Dinh CH; Wang H; Cheng L; Huang XF
    Mol Cell Endocrinol; 2015 Sep; 412():36-43. PubMed ID: 26001833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
    Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
    PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
    Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.